Copyright
©The Author(s) 2023.
World J Orthop. Dec 18, 2023; 14(12): 878-888
Published online Dec 18, 2023. doi: 10.5312/wjo.v14.i12.878
Published online Dec 18, 2023. doi: 10.5312/wjo.v14.i12.878
Characteristic | Treatment group | Correlation coefficient (r) | Control group | Correlation coefficient (r) |
Number of patients (n) | 40 | 15 | ||
Age (mean ± SD) | 42.2 ± 8.49 | -0.1124a; 0.099b | 38.06 ± 5.98 | 0.4919a; 0.045b |
Gender (M:F) | 18:22 | 0.2353a; -0.08b | 11:4 | 0.1183a; -0.34b |
NSLBP:LDH | 1:1 | -0.131a; 0.126b | 7:8 | 0.1396a; 0.172b |
NPRS – how would you rate your pain right now? | 6.48 ± 1.63 | 8.07 ± 1.16 | ||
JOABPEQ – low back pain | 8.9 ± 14.38 | 10.40 ± 12.66 |
NPRS parameters | Initial | 1 mo (mean ± SD) | 3 mo | P value | ||
Treatment group | How would you rate your pain RIGHT NOW | 6.48 ± 1.63 | 4.63 ± 1.00 | 3.18 ± 1.87 | < 0.001 | |
P value | < 0.001a | < 0.001b | ||||
USUAL level of pain during the last week | 6.35 ± 1.23 | 4.18 ± 0.96 | 3.0 ± 1.43 | < 0.001 | ||
P value | < 0.001a | < 0.001b | ||||
BEST level of pain during the last week | 5.78 ± 1.25 | 3.78 ± 0.97 | 2.18 ± 1.62 | < 0.001 | ||
P value | < 0.001a | < 0.001b | ||||
WORST level of pain during the last week | 7.9 ± 1.50 | 4.93 ± 1.10 | 3.6 ± 2.01 | < 0.001 | ||
P value | < 0.001a | < 0.001b | ||||
Control group | How would you rate your pain RIGHT NOW | 8.07 ± 1.16 | 8.4 ± 0.63 | 8.47 ± 0.64 | > 0.05 | |
P value | > 0.05a | > 0.05b | ||||
USUAL level of pain during the last week | 7.53 ± 0.92 | 8.13 ± 0.52 | 8.67 ± 0.49 | > 0.05 | ||
P value | > 0.05a | > 0.05b | ||||
BEST level of pain during the last week | 7.33 ± 0.98 | 7.87 ± 0.64 | 8.13 ± 0.74 | > 0.05 | ||
P value | > 0.05a | > 0.05b | ||||
WORST level of pain during the last week | 8.73 ± 1.10 | 8.67 ± 0.49 | 9.00 ± 0.38 | > 0.05 | ||
P value | > 0.05a | > 0.05b |
JOABPEQ functional domains | Initial evaluation | Final evaluation | Difference | P value | |
Treatment group | Low back pain | 8.9 ± 14.38 | 75.05 ± 20.97 | 66.15 | < 0.001 |
Lumbar function | 20.08 ± 18.24 | 60.25 ± 18.38 | 40.17 | < 0.001 | |
Walking ability | 23.38 ± 19.09 | 55.73 ± 21.07 | 32.35 | < 0.001 | |
Social life function | 19.83 ± 14.02 | 55.50 ± 17.37 | 35.67 | < 0.001 | |
Mental health | 31.78 ± 20.85 | 67.35 ± 13.83 | 35.57 | < 0.001 | |
Control group | Low back pain | 10.40 ± 12.66 | 6.67 ± 13.13 | -3.73 | 0.29 |
Lumbar function | 39.40 ± 25.57 | 17.73 ± 14.69 | -21.67 | 0.01 | |
Walking ability | 23.80 ± 30.96 | 14.20 ± 16.01 | -9.6 | 0.69 | |
Social life function | 33.07 ± 24.10 | 13.87 ± 9.24 | -19.2 | 0.01 | |
Mental health | 31.93 ± 19.76 | 12.80 ± 6.83 | -19.13 | < 0.001 |
- Citation: Allen S, Rashid A, Adjani A, Akram M, Khan FS, Sherwani R, Khalil MT. Efficacy and safety of thermobalancing therapy with Dr Allen’s Device for chronic low back pain: A randomised controlled trial. World J Orthop 2023; 14(12): 878-888
- URL: https://www.wjgnet.com/2218-5836/full/v14/i12/878.htm
- DOI: https://dx.doi.org/10.5312/wjo.v14.i12.878